Low platelet alpha 2 beta 1 levels in patients with von Willebrand disease type I represents an increased risk factor for bleeding.

被引：0
|
作者：
DiPaola, J
Federici, AB
Sacchi, E
Canciani, MT
Mannucci, PM
Kritzik, M
Kunicki, T
Nugent, D
机构：
[1] SCRIPPS INST,LA JOLLA,CA
[2] A BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR,MILAN,ITALY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] Effect of Genetic Variation in STXBP5 and STX2 on von Willebrand Factor and Bleeding Phenotype in Type 1 von Willebrand Disease Patients
    van Loon, Janine E.
    Sanders, Yvonne V.
    de Wee, Eva M.
    Kruip, Marieke J. H. A.
    de Maat, Moniek P. M.
    Leebeek, Frank W. G.
    PLOS ONE, 2012, 7 (07):
  • [32] Misfolding of the von Willebrand factor A1 domain in Type 2 von Willebrand disease
    Auton, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 90 - 90
  • [33] THE UTILITY OF THE DDAVP CHALLENGE TEST IN PATIENTS WITH LOW VON WILLEBRAND FACTOR LEVELS AND VON WILLEBRAND DISEASE (VWD)
    Archer, Natasha
    Samnaliev, Mihail
    Grace, Rachael
    Brugnara, Carlo
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S20 - S20
  • [34] Platelet adhesion at high shear rates: The roles of von Willebrand factor/GPIb and the beta(1) integrin alpha(2)beta(1)
    Gralnick, HR
    Kramer, WS
    McKeown, LP
    Garfinkel, L
    Pinot, A
    Williams, SB
    Krutzsch, H
    THROMBOSIS RESEARCH, 1996, 81 (01) : 113 - 119
  • [35] Recombinant coagulation factor VIIa in the management of bleeding in patients with von Willebrand disease type 2A
    Matyskova, M
    Vorlova, Z
    Habart, D
    Martinkova, I
    Bulikova, A
    Dulicek, P
    Ptak, J
    TRANSFUSION AND APHERESIS SCIENCE, 2004, 31 (01) : 75 - 77
  • [36] An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type I von Willebrand disease
    Cumming, Anthony
    Grundy, Pamela
    Keeney, Stephen
    Lester, William
    Enayat, Said
    Guilliatt, Andrea
    Bowen, Derrick
    Pasi, John
    Keeling, David
    Hill, Frank
    Bolton-Maggs, Paula H. B.
    Hay, Charles
    Collins, Peter
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (05) : 630 - 641
  • [37] Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease
    Sztukowska, M.
    Gallinaro, L.
    Cattini, M. G.
    Pontara, E.
    Sartorello, F.
    Daidone, V.
    Padrini, R.
    Pagnan, A.
    Casonato, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (01) : 107 - 114
  • [38] Pharmacokinetics of von Willebrand factor and factor VIII coagulant activity in patients with von Willebrand disease type 3 and type 2
    Menache, D
    HAEMOPHILIA, 1998, 4 : 44 - 47
  • [39] A comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays
    Colpani, Paola
    Baronciani, Luciano
    Stufano, Francesca
    Cozzi, Giovanna
    Boscarino, Marco
    Pagliari, Maria Teresa
    Biguzzi, Eugenia
    Peyvandi, Flora
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (03)
  • [40] Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene
    Nurden, Paquita
    Nurden, Alan T.
    La Marca, Silvia
    Punzo, Margherita
    Baronciani, Luciano
    Federici, Augusto B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (11): : 1627 - 1629
12345